Home/Pipeline/Antibiotic-free Genetic Selection

Antibiotic-free Genetic Selection

Biomanufacturing/Recombinant Protein Production

Research/DevelopmentActive

Key Facts

Indication
Biomanufacturing/Recombinant Protein Production
Phase
Research/Development
Status
Active
Company

About Syngulon

Syngulon is a Belgium-based synthetic biology company leveraging bacteriocins to create novel genetic tools for industrial biotechnology and healthcare. Operating as a 'Startup in the Labs,' it collaborates closely with academic partners across Europe and the US to develop its PARAGEN collection of natural and synthetic bacteriocins. The company's platform addresses critical industry challenges including the need for antibiotic-free biomanufacturing, robust contamination control, and new antimicrobials to combat rising resistance. Its approach is underpinned by a distinguished Scientific Advisory Board with deep expertise in microbiology and bacterial genetics.

View full company profile